CalciMedica Secures $49M Financing to Advance PH Program
LA JOLLA, Calif., June 24, 2026 CalciMedica, Inc. (Nasdaq: CALC) announced a private placement financing of up to approximately...
CRAC Channel Inhibitor
Advertisement
CalciMedica Receives FDA Clearance to Continue Auxora KOURAGE Trial
LA JOLLA, Calif., June 24, 2026 CalciMedica, Inc. announced that the U.S. Food and Drug Administration (FDA) has completed...
Advertisement
